Stock Scorer

Cardlytics, Inc. (CDLX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. Every figure as a table ›

Revenue Quarterly

0 35M 70M 105M Q3 '21: 65M Q4 '21: 90M Q1 '22: 67.9M Q2 '22: 75.4M Q3 '22: 72.7M Q4 '22: 82.5M Q1 '23: 64.3M Q2 '23: 76.7M Q3 '23: 79M Q4 '23: 89.2M Q1 '24: 67.6M Q2 '24: 69.6M Q3 '24: 67.1M Q4 '24: 74M Q1 '25: 56.4M Q2 '25: 58M Q3 '25: 52M Q4 '25: 56.1M Q1 '26: 34.3M Q2 '26: 36.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '21: -39.8M Q4 '21: -16.4M Q1 '22: 35.7M Q2 '22: -122.3M Q3 '22: 11.5M Q4 '22: -382.6M Q1 '23: 12.2M Q2 '23: -24.3M Q3 '23: -20.7M Q4 '23: -102.9M Q1 '24: -22.8M Q2 '24: -15.8M Q3 '24: -148.5M Q4 '24: -8.3M Q1 '25: -11.1M Q2 '25: -9.6M Q3 '25: -68.9M Q4 '25: -6.1M Q1 '26: -8.3M Q2 '26: -5.4M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-450M -300M -150M 0 150M 300M 450M Q3 '21: -44.5M Q4 '21: -11.8M Q1 '22: 33M Q2 '22: -126.3M Q3 '22: 6.3M Q4 '22: -378.3M Q1 '23: 13.6M Q2 '23: -23.5M Q3 '23: -24M Q4 '23: -100.8M Q1 '24: -24.3M Q2 '24: -4.3M Q3 '24: -145.2M Q4 '24: -15.6M Q1 '25: -13.3M Q2 '25: -9.3M Q3 '25: -72.7M Q4 '25: -8.2M Q1 '26: -4.5M Q2 '26: -14.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '21: -10.5M Q4 '21: -555K Q1 '22: -19.7M Q2 '22: -6.7M Q3 '22: -14.4M Q4 '22: -13.1M Q1 '23: -10.1M Q2 '23: 5.8M Q3 '23: 1.2M Q4 '23: 2.9M Q1 '24: -17.6M Q2 '24: 4.4M Q3 '24: 1.4M Q4 '24: 3M Q1 '25: -6.7M Q2 '25: 1.2M Q3 '25: 1.8M Q4 '25: 13M Q1 '26: -5.6M Q2 '26: -8.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-21M -14M -7M 0 7M 14M 21M Q3 '21: -10.8M Q4 '21: -1.5M Q1 '22: -20.1M Q2 '22: -7.2M Q3 '22: -14.6M Q4 '22: -13.2M Q1 '23: -10.4M Q2 '23: 5.7M Q3 '23: 1.1M Q4 '23: 2.7M Q1 '24: -18.3M Q2 '24: 4.1M Q3 '24: 878K Q4 '24: 2.9M Q1 '25: -6.8M Q2 '25: 903K Q3 '25: 1.7M Q4 '25: 13M Q1 '26: -5.7M Q2 '26: -8.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q2 '17: 3.9M Q2 '18: 20.3M Q3 '20: 33.1M Q1 '21: 29.3M Q2 '21: 33M Q3 '21: 33.1M Q1 '22: 37.2M Q2 '22: 33.6M Q3 '22: 33.3M Q1 '23: 36.7M Q2 '23: 34.9M Q3 '23: 38M Q1 '24: 43.2M Q2 '24: 49.1M Q3 '24: 50M Q1 '25: 51.9M Q2 '25: 5.3M Q3 '25: 53.5M Q1 '26: 54.9M Q2 '26: 5.8M Q2 '18 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q2 '20: -1.39 Q3 '20: -2.41 Q4 '20: -2.83 Q1 '21: -3.17 Q2 '21: -3.87 Q3 '21: -3.87 Q4 '21: -3.95 Q1 '22: -2.19 Q2 '22: -4.51 Q3 '22: -2.97 Q4 '22: -13.97 Q1 '23: -14.48 Q2 '23: -11.40 Q3 '23: -12.22 Q4 '23: -3.64 Q1 '24: -4.60 Q2 '24: -4.02 Q3 '24: -6.29 Q4 '24: -3.80 Q1 '25: -3.50 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for CDLX: Gross Profit, Cost of Revenue. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.